Urothelial dysplasia of the bladder: Diagnostic features and clinical significance

Antonio Lopez-Beltran, Rodolfo Montironi, Alfredo Vidal, Marina Scarpelli, Liang Cheng

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The 2004 World Health Organization classification system for urothelial neoplasia identifies urothelial dysplasia (low-grade intraurothelial neoplasia) as a premalignant lesion of the urothelium. Although diagnostic criteria of urothelial dysplasia have been improved in recent years, there is a frequent lack of interobserver reproducibility. Follow-up studies suggest that dysplasia is a marker for urothelial instability and disease progression in up to 19% of patients, thus supporting an active clinical follow-up in these patients. The main differential diagnosis of urothelial dysplasia includes flat urothelial lesions with atypia, mainly flat (simple) urothelial hyperplasia, reactive urothelial atypia, urothelial atypia of unknown significance, and urothelial carcinoma in situ (high-grade intraurothelial neoplasia). In most cases, morphologic features alone suffice for diagnosis. Some cases may require a panel of immunohistochemical antibodies consisting of cytokeratin 20, p53 and CD44 for diagnosis. We present pathologic features and clinical significance of urothelial dysplasia with emphasis on differential diagnosis from common flat urothelial lesions with atypia. (Anal Quant Cytopathol Histopathol 2013;35:121-129).

Original languageEnglish
Pages (from-to)121-129
Number of pages9
JournalAnalytical and Quantitative Cytology and Histology
Volume35
Issue number3
StatePublished - Jun 2013

Fingerprint

Urinary Bladder
Differential Diagnosis
Keratin-20
Urothelium
Neoplasms
Carcinoma in Situ
Hyperplasia
Disease Progression
Antibodies

Keywords

  • Carcinoma in situ
  • Diagnosis
  • Intraepithelial neoplasms
  • Pathology
  • Urothelial dysplasia
  • Urothelium

ASJC Scopus subject areas

  • Anatomy
  • Histology

Cite this

Urothelial dysplasia of the bladder : Diagnostic features and clinical significance. / Lopez-Beltran, Antonio; Montironi, Rodolfo; Vidal, Alfredo; Scarpelli, Marina; Cheng, Liang.

In: Analytical and Quantitative Cytology and Histology, Vol. 35, No. 3, 06.2013, p. 121-129.

Research output: Contribution to journalArticle

Lopez-Beltran, Antonio ; Montironi, Rodolfo ; Vidal, Alfredo ; Scarpelli, Marina ; Cheng, Liang. / Urothelial dysplasia of the bladder : Diagnostic features and clinical significance. In: Analytical and Quantitative Cytology and Histology. 2013 ; Vol. 35, No. 3. pp. 121-129.
@article{eb996d444dc145acbd717f8597bcee84,
title = "Urothelial dysplasia of the bladder: Diagnostic features and clinical significance",
abstract = "The 2004 World Health Organization classification system for urothelial neoplasia identifies urothelial dysplasia (low-grade intraurothelial neoplasia) as a premalignant lesion of the urothelium. Although diagnostic criteria of urothelial dysplasia have been improved in recent years, there is a frequent lack of interobserver reproducibility. Follow-up studies suggest that dysplasia is a marker for urothelial instability and disease progression in up to 19{\%} of patients, thus supporting an active clinical follow-up in these patients. The main differential diagnosis of urothelial dysplasia includes flat urothelial lesions with atypia, mainly flat (simple) urothelial hyperplasia, reactive urothelial atypia, urothelial atypia of unknown significance, and urothelial carcinoma in situ (high-grade intraurothelial neoplasia). In most cases, morphologic features alone suffice for diagnosis. Some cases may require a panel of immunohistochemical antibodies consisting of cytokeratin 20, p53 and CD44 for diagnosis. We present pathologic features and clinical significance of urothelial dysplasia with emphasis on differential diagnosis from common flat urothelial lesions with atypia. (Anal Quant Cytopathol Histopathol 2013;35:121-129).",
keywords = "Carcinoma in situ, Diagnosis, Intraepithelial neoplasms, Pathology, Urothelial dysplasia, Urothelium",
author = "Antonio Lopez-Beltran and Rodolfo Montironi and Alfredo Vidal and Marina Scarpelli and Liang Cheng",
year = "2013",
month = "6",
language = "English",
volume = "35",
pages = "121--129",
journal = "Analytical and Quantitative Cytopathology and Histopathology",
issn = "0301-102X",
publisher = "John Rylands University Library",
number = "3",

}

TY - JOUR

T1 - Urothelial dysplasia of the bladder

T2 - Diagnostic features and clinical significance

AU - Lopez-Beltran, Antonio

AU - Montironi, Rodolfo

AU - Vidal, Alfredo

AU - Scarpelli, Marina

AU - Cheng, Liang

PY - 2013/6

Y1 - 2013/6

N2 - The 2004 World Health Organization classification system for urothelial neoplasia identifies urothelial dysplasia (low-grade intraurothelial neoplasia) as a premalignant lesion of the urothelium. Although diagnostic criteria of urothelial dysplasia have been improved in recent years, there is a frequent lack of interobserver reproducibility. Follow-up studies suggest that dysplasia is a marker for urothelial instability and disease progression in up to 19% of patients, thus supporting an active clinical follow-up in these patients. The main differential diagnosis of urothelial dysplasia includes flat urothelial lesions with atypia, mainly flat (simple) urothelial hyperplasia, reactive urothelial atypia, urothelial atypia of unknown significance, and urothelial carcinoma in situ (high-grade intraurothelial neoplasia). In most cases, morphologic features alone suffice for diagnosis. Some cases may require a panel of immunohistochemical antibodies consisting of cytokeratin 20, p53 and CD44 for diagnosis. We present pathologic features and clinical significance of urothelial dysplasia with emphasis on differential diagnosis from common flat urothelial lesions with atypia. (Anal Quant Cytopathol Histopathol 2013;35:121-129).

AB - The 2004 World Health Organization classification system for urothelial neoplasia identifies urothelial dysplasia (low-grade intraurothelial neoplasia) as a premalignant lesion of the urothelium. Although diagnostic criteria of urothelial dysplasia have been improved in recent years, there is a frequent lack of interobserver reproducibility. Follow-up studies suggest that dysplasia is a marker for urothelial instability and disease progression in up to 19% of patients, thus supporting an active clinical follow-up in these patients. The main differential diagnosis of urothelial dysplasia includes flat urothelial lesions with atypia, mainly flat (simple) urothelial hyperplasia, reactive urothelial atypia, urothelial atypia of unknown significance, and urothelial carcinoma in situ (high-grade intraurothelial neoplasia). In most cases, morphologic features alone suffice for diagnosis. Some cases may require a panel of immunohistochemical antibodies consisting of cytokeratin 20, p53 and CD44 for diagnosis. We present pathologic features and clinical significance of urothelial dysplasia with emphasis on differential diagnosis from common flat urothelial lesions with atypia. (Anal Quant Cytopathol Histopathol 2013;35:121-129).

KW - Carcinoma in situ

KW - Diagnosis

KW - Intraepithelial neoplasms

KW - Pathology

KW - Urothelial dysplasia

KW - Urothelium

UR - http://www.scopus.com/inward/record.url?scp=84880029607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880029607&partnerID=8YFLogxK

M3 - Article

C2 - 24344498

AN - SCOPUS:84880029607

VL - 35

SP - 121

EP - 129

JO - Analytical and Quantitative Cytopathology and Histopathology

JF - Analytical and Quantitative Cytopathology and Histopathology

SN - 0301-102X

IS - 3

ER -